About
Cornelia Kröger, PhD, is affiliated with DAJE Lifesciences, LLC in Somerville, Massachusetts. Kröger has published multiple articles on the use of esmethadone (REL-1017) in patients with major depressive disorder (MDD), focusing on its efficacy, safety, and effects in cases with antidepressant tachyphylaxis or inadequate response to standard treatments. The research includes exploratory analyses from phase 3 randomized controlled trials and long-term open-label studies. Frequent collaborators include Andrea Mattarei, Clotilde Guidetti, Franco Folli, Luca Pani, and Marco Pappagallo.
